Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The obligation not to abandon the patient].
Borrell F, Júdez J, Luis Segovia J, Sobrino A, Alvarez T; Proyecto de Bioética para Clínicos del Instituto de Bioética de la Fundación de Ciencias de la Salud. Borrell F, et al. Among authors: alvarez t. Med Clin (Barc). 2001 Sep 15;117(7):262-73. doi: 10.1016/s0025-7753(01)72081-7. Med Clin (Barc). 2001. PMID: 11562330 Spanish. No abstract available.
Air pollution and health prevention: A document of reflection.
Bouza E, Vargas F, Alcázar B, Álvarez T, Asensio A, Cruceta G, Gracia D, Guinea J, Gil MA, Linares C, Muñoz P, Pastor P, Pedro-Botet ML, Querol X, Tovar J, Urrutia I, Villar F, Palomo E. Bouza E, et al. Among authors: alvarez t. Rev Esp Quimioter. 2022 Aug;35(4):307-332. doi: 10.37201/req/171.2021. Epub 2022 Mar 11. Rev Esp Quimioter. 2022. PMID: 35277084 Free PMC article. Review.
Characteristics and Outcomes of Children and Young Adults With Sepsis Requiring Continuous Renal Replacement Therapy: A Comparative Analysis From the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK).
Stanski NL, Gist KM, Hasson D, Stenson EK, Seo J, Ollberding NJ, Muff-Luett M, Cortina G, Alobaidi R, See E, Kaddourah A, Fuhrman DY; Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) Investigators. Stanski NL, et al. Crit Care Med. 2024 Nov 1;52(11):1686-1699. doi: 10.1097/CCM.0000000000006405. Epub 2024 Sep 11. Crit Care Med. 2024. PMID: 39258974
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Evering TH, Moser C, Jilg N, Ritz J, Wohl DA, Li JZ, Margolis D, Javan AC, Eron JJ, Currier JS, Daar ES, Smith DM, Hughes MD, Chew KW; ACTIV-2/A5401 Study Team. Evering TH, et al. EClinicalMedicine. 2024 Aug 16;75:102787. doi: 10.1016/j.eclinm.2024.102787. eCollection 2024 Sep. EClinicalMedicine. 2024. PMID: 39252866 Free PMC article.
Characteristics and outcomes of children ≤ 10 kg receiving continuous kidney replacement therapy: a WE-ROCK study.
Menon S, Starr MC, Zang H, Collins M, Damian MA, Fuhrman D, Krallman K, Soranno DE, Webb TN, Slagle C, Joseph C, Martin SD, Mohamed T, Beebe ME, Ricci Z, Ollberding N, Selewski D, Gist KM; WE-ROCK investigators. Menon S, et al. Pediatr Nephrol. 2025 Jan;40(1):253-264. doi: 10.1007/s00467-024-06438-x. Epub 2024 Aug 20. Pediatr Nephrol. 2025. PMID: 39164502
237 results